Comparing Winograd versus sleeve (gutter) method for treating ingrown toenails
Official title: COMPARISON OF TWO SURGICAL METHODS (WINOGRAD VS SLEEVE METHOD) IN THE TREATMENT OF INGROWN TOE NAIL
Run by Pakistan Institute of Medical Sciences · NCT07547241 · Data updated 2026-11-12
This randomized study will test whether the Winograd procedure or the sleeve (gutter) method better reduces recurrence of ingrown toenails in patients needing surgical treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 75 Years |
| Sex | All |
| Enrollment | 312 (estimated) |
| Sponsor | Pakistan Institute of Medical Sciences Government |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Islamabad) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT07547241 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 12–75 with a primary ingrown toenail requiring surgery who can give informed consent and do not have the listed exclusion conditions.
✕Probably not a fit
Patients with diabetes, peripheral vascular disease, immunocompromise, coagulopathy, active local infection, or prior/recurrent ingrown toenail surgery are excluded and unlikely to benefit from the trial results.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized clinical trial will enroll 312 affected nails and assign them equally to receive either the Winograd partial nail avulsion with matrix excision or the sleeve (gutter) method performed under standardized conditions. Procedures will be done by trained surgical residents in a tertiary care hospital and patients will be followed for 30 days after the intervention to record recurrence and other clinical outcomes. Key exclusions include diabetes, peripheral vascular disease, immunocompromise, coagulopathy, active local infection, prior or recurrent ingrown toenail surgery, or delayed complications from previous surgery. The study aims to produce locally relevant comparative data to guide choice of surgical technique for onychocryptosis.
Why it matters
Potential benefit: If one method shows lower recurrence, patients could have fewer repeat procedures, less pain, and faster return to normal activity.
How similar studies have gone: Previous reports show mixed recurrence rates for both techniques and no clear consensus, so direct comparisons remain limited and context-dependent.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients presenting with ingrown toenail (onychocryptosis) * Patients for whom surgical intervention is indicated * Age between 12 and 75 years * Both male and female participants * Patients willing to provide informed consent Exclusion Criteria: * Patients with diabetes mellitus * Patients with peripheral vascular disease * Immunocompromised patients * Patients with coagulopathy * Patients receiving chemotherapy * Patients with localized infection or abscess at the surgical site * Patients with previously treated or recurrent ingrown toenail * Patients presenting with delayed complications of prior ingrown toenail surgery
Where it's running
-
Pakistan Institute of Medical Sciences
Islamabad, Pakistan Recruiting
Study contacts
- Principal investigator: Dr Muhammad Fahad Ali, Mbbs — Pakistan Institute of Medical Sciences
- Study coordinator: Muhammad Fahad Ali, MBBS, MRCS
- Email: joyafahad@gmail.com
- Phone: +923320601136
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality to reduce pain and anxiety during ingrown toenail surgery
In adults having outpatient ingrown toenail surgery under local anesthesia, this study tests whether using virtual reality helps reduce pain and anxiety compared with standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.